CH-REP – Swiss Authorized Representative

Swiss Authorized Representative (CH-REP)

Since Switzerland updated its Medical Devices Regulation (MepV, MedDO) and In Vitro Diagnostic Devices (IvDO) to implement the MDR/IVDR into Swiss law, Switzerland became a “third country” in Europe due to the lack of an MRA. Therefore, medical device and IVD manufacturers outside Switzerland must appoint a local Swiss authorized representative.

What does the CH-REP for me?

As a Swiss authorized representative, we handle and support you in particular with the following requirements:

Have we piqued your interest? Here you will find further information about our service and the legal requirements.

A Swissmedic leaflet about obligations of Manufacturer, CH-REP and CH-IMPORTER
your application form to get us your CH-REP in Switzerland
Also need an IMPORTER for your products in Switzerland?

More questions? See our FAQ about CH-REP:

A Swiss Authorized Representative is defined as being any natural or legal person established within Switzerland who has received and accepted a written mandate from a manufacturer located outside Switzerland to act on the manufacturer’s behalf in relation to specified tasks about the latter’s obligations under the regulations.
If you do not have a place of business in Switzerland, you must appoint a CH-REP to place medical devices onto the market as it is required by Swiss regulations.

The annual fee for our service as CH-REP is CHF 1’500.00 per year, no matter how many products or what kind of Risk Class you have.

For review and approve of your products a one time fee for each product cathegory of for Risk Class I is CHF 1’600.00 and CHF 600.00 for all other Risk Classes.

No. Art.51 Par.1 of the MedDo as amended simply refers ot Art. 11 of the MDR. However, to be able to perform the tasks elaborated in that article, it is obvious that the Authorized Representative has to have in-house adequate experience and skills to perform the tasks. Were that not the case, the liability referred to in par. 5 of the MDR would be unsupportable.

Yes, it does. Art. 49 par. 2 of the MedDo specifically refers to Art. 15 MDR, including the qualifications mentioned there. However, in an unexpected gesture to the EU, the PRRC of the CH REP may be based in EU, should the CH REP so decide.

After you submitted us the requested company and product documentation, it takes about 5 business days per product cathegory to review and approve the registration as CH-REP.

No, you don’t need to change anything. However, to apply with MDR regulations you need to label the CH-REP information on your product or package, but this can be done with an aditional sticker if a change on your current label is not applicable.

Your product don’t need to be certified as an MDR to register and sell them in Switzerland. With a valid MDD certificate or certification extension the CH-REP registration can still be done.

The CH-REP has to be on a labeling component that will be available to the end-user at the point of use, e.g. shelf box or sterile packaging, preferentially but not mandatorily on the device label. For products that are still certified under MDD, the CH REP may be on the IFU, if the IFU accompanies the product to the point-of-use, similar to the European Authorized Representative.

Your Swiss Partner for Quality Management and Regulatory compliance!